je.st
news
Tag: collaboration
NGM And Merck Announce Broad Strategic Collaboration To Discover, Develop And Commercialize Novel Biologic Therapeutics
2015-03-04 04:25:06| drugdiscoveryonline News Articles
NGM Biopharmaceuticals, Inc., a privately-held biotechnology company and Merck, known as MSD outside the United States and Canada, recently announced they have entered into a multi-year collaboration to research, discover, develop and commercialize novel biologic therapies across a wide range of therapeutic areas
Tags: develop
broad
discover
collaboration
The Human Side of Technology: Why Workers Won't Use Collaboration Software
2015-03-03 21:15:39| ENR.com: Headline News
How to build human connections in your project team to encourage the use of collaboration software.
Tags: software
technology
side
human
OmniVision and eyeSight Collaboration Brings Gesture Recognition Technology to a Wide Range of Applications
2015-02-27 11:31:02| Industrial Newsroom - All News for Today
SANTA CLARA, Calif. OmniVision Technologies, Inc. (NASDAQ: OVTI), a leading developer of advanced digital imaging solutions, and eyeSight Technologies Ltd., a leader in machine vision and gesture recognition technology, today announced their co-development of next-generation gesture recognition technology in the...
Tags: of
range
technology
wide
Collaboration System, Intellinote, Extends Capabilities of Third-Party Software
2015-02-26 18:35:59| ENR.com: Headline News
A cloud-based enterprise collaboration systems new field management tool lets users edit, annotate and share service requests between the field and the office on iOS devices.
Tags: system
software
collaboration
capabilities
Merck Announces Collaboration with the Medicines Patent Pool to Expand Access to Pediatric Formulations of Raltegravir in Developing Countries
2015-02-24 09:00:00| Merck.com - Product News
Dateline City: KENILWORTH, N.J. KENILWORTH, N.J.--(BUSINESS WIRE)--Merck (NYSE:MRK), known as MSD outside the United States and Canada, today announced an agreement with the Medicines Patent Pool (MPP) to license its pediatric formulations of raltegravir for use in treating HIV-1 infection in infants and children from four weeks to under 12 years of age in developing countries. This is the MPPs first agreement to provide access to an HIV integrase inhibitor for use in combination HIV therapy for infants and children in this age range. Language: English Contact: MerckMedia:Pam Eisele, 267-305-3558Ian McConnell, 908-740-1921orInvestors:Joe Romanelli, 908-740-1986Justin Holko, 908-740-1879 Ticker Slug: Ticker: MRK Exchange: NYSE read more
Tags: access
countries
expand
pool
Sites : [76] [77] [78] [79] [80] [81] [82] [83] [84] [85] [86] [87] [88] [89] [90] [91] [92] [93] [94] [95] next »